Cargando…

Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) and neurofibromatosis type 1 (NF1) are both autosomal dominant disorders with a high rate of novel mutations. However, the two disorders have distinct and well‐delineated genetic, biochemical, and clinical findings. Only a few cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Peces, Ramón, Mena, Rocío, Martín, Yolanda, Hernández, Concepción, Peces, Carlos, Tellería, Dolores, Cuesta, Emilio, Selgas, Rafael, Lapunzina, Pablo, Nevado, Julián
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434601/
https://www.ncbi.nlm.nih.gov/pubmed/32533764
http://dx.doi.org/10.1002/mgg3.1321
_version_ 1783572183111434240
author Peces, Ramón
Mena, Rocío
Martín, Yolanda
Hernández, Concepción
Peces, Carlos
Tellería, Dolores
Cuesta, Emilio
Selgas, Rafael
Lapunzina, Pablo
Nevado, Julián
author_facet Peces, Ramón
Mena, Rocío
Martín, Yolanda
Hernández, Concepción
Peces, Carlos
Tellería, Dolores
Cuesta, Emilio
Selgas, Rafael
Lapunzina, Pablo
Nevado, Julián
author_sort Peces, Ramón
collection PubMed
description BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) and neurofibromatosis type 1 (NF1) are both autosomal dominant disorders with a high rate of novel mutations. However, the two disorders have distinct and well‐delineated genetic, biochemical, and clinical findings. Only a few cases of coexistence of ADPKD and NF1 in a single individual have been reported, but the possible implications of this association are unknown. METHODS: We report an ADPKD male belonging to a family of several affected members in three generations associated with NF1 and optic pathway gliomas. The clinical diagnosis of ADPKD and NF1 was performed by several image techniques. RESULTS: Linkage analysis of ADPKD family was consistent to the PKD2 locus by a nonsense mutation, yielding a truncated polycystin‐2 by means of next‐generation sequencing. The diagnosis of NF1 was confirmed by mutational analysis of this gene showing a 4‐bp deletion, resulting in a truncated neurofibromin, as well. The impact of this association was investigated by analyzing putative genetic interactions and by comparing the evolution of renal size and function in the proband with his older brother with ADPKD without NF1 and with ADPKD cohorts. CONCLUSION: Despite the presence of both conditions there was not additive effect of NF1 and PKD2 in terms of the severity of tumor development and/or ADPKD progression.
format Online
Article
Text
id pubmed-7434601
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74346012020-08-20 Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2 Peces, Ramón Mena, Rocío Martín, Yolanda Hernández, Concepción Peces, Carlos Tellería, Dolores Cuesta, Emilio Selgas, Rafael Lapunzina, Pablo Nevado, Julián Mol Genet Genomic Med Original Articles BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) and neurofibromatosis type 1 (NF1) are both autosomal dominant disorders with a high rate of novel mutations. However, the two disorders have distinct and well‐delineated genetic, biochemical, and clinical findings. Only a few cases of coexistence of ADPKD and NF1 in a single individual have been reported, but the possible implications of this association are unknown. METHODS: We report an ADPKD male belonging to a family of several affected members in three generations associated with NF1 and optic pathway gliomas. The clinical diagnosis of ADPKD and NF1 was performed by several image techniques. RESULTS: Linkage analysis of ADPKD family was consistent to the PKD2 locus by a nonsense mutation, yielding a truncated polycystin‐2 by means of next‐generation sequencing. The diagnosis of NF1 was confirmed by mutational analysis of this gene showing a 4‐bp deletion, resulting in a truncated neurofibromin, as well. The impact of this association was investigated by analyzing putative genetic interactions and by comparing the evolution of renal size and function in the proband with his older brother with ADPKD without NF1 and with ADPKD cohorts. CONCLUSION: Despite the presence of both conditions there was not additive effect of NF1 and PKD2 in terms of the severity of tumor development and/or ADPKD progression. John Wiley and Sons Inc. 2020-06-13 /pmc/articles/PMC7434601/ /pubmed/32533764 http://dx.doi.org/10.1002/mgg3.1321 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Peces, Ramón
Mena, Rocío
Martín, Yolanda
Hernández, Concepción
Peces, Carlos
Tellería, Dolores
Cuesta, Emilio
Selgas, Rafael
Lapunzina, Pablo
Nevado, Julián
Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title_full Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title_fullStr Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title_full_unstemmed Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title_short Co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
title_sort co‐occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434601/
https://www.ncbi.nlm.nih.gov/pubmed/32533764
http://dx.doi.org/10.1002/mgg3.1321
work_keys_str_mv AT pecesramon cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT menarocio cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT martinyolanda cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT hernandezconcepcion cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT pecescarlos cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT telleriadolores cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT cuestaemilio cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT selgasrafael cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT lapunzinapablo cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2
AT nevadojulian cooccurrenceofneurofibromatosistype1andopticnervegliomaswithautosomaldominantpolycystickidneydiseasetype2